
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Aveanna Healthcare (AVAH) and Chemed (CHE). But which of these two stocks presents investors with the better value opportunity right now?
Chemed Corporation provides hospice and hospice services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers across the United States. The company is headquartered in Cincinnati, Ohio.
| Revenue (TTM) | $2.60B |
| Gross Profit (TTM) | $859.31M |
| EBITDA | $416.92M |
| Operating Margin | 13.30% |
| Return on Equity | 27.10% |
| Return on Assets | 13.50% |
| Revenue/Share (TTM) | $187.96 |
| Book Value | $63.81 |
| Price-to-Book | 8.39 |
| Price-to-Sales (TTM) | 2.64 |
| EV/Revenue | 2.782 |
| EV/EBITDA | 16.45 |
| Quarterly Earnings Growth (YoY) | 43.70% |
| Quarterly Revenue Growth (YoY) | 8.80% |
| Shares Outstanding | $13.07M |
| Float | $11.85M |
| % Insiders | 1.95% |
| % Institutions | 106.77% |
Volatility is currently contracting

Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Aveanna Healthcare (AVAH) and Chemed (CHE). But which of these two stocks presents investors with the better value opportunity right now?

Chemed Corporation (CHE) receives a Buy rating with a $632/share target, driven by activist pressure for a spin-off to eliminate the conglomerate discount. VITAS has successfully reengineered its patient mix, sharply reducing Medicare Cap penalties and driving 8.8% revenue growth and 18.2% Adjusted EBITDA margin in Q2. Roto-Rooter faces structural margin pressure from rising digital marketing costs, but B2B expansion and operational efficiencies are expected to support future growth.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Chemed NYSE: CHE reported second-quarter 2026 results marked by stronger-than-expected performance at its VITAS hospice business, while Roto-Rooter delivered revenue growth but continued to face higher customer-acquisition costs.

CINCINNATI, July 28, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its second quarter ended June 30, 2026, versus the comparable prior-year period. Results for Quarter Ended June 30, 2026 Consolidated operating results: Revenue increased 8.8% to $673.3 million GAAP Diluted Earnings-per-Share (EPS) of $5.13, an increase of 43.7% Adjusted Diluted EPS of $6.06, an increase of 41.9% VITAS segment operating results: Net Patient Revenue of $443.3 million, an increase of 11.9% Average Daily Census (ADC) of 23,687, an increase of 6.1% Admissions of 19,125, an increase of 9.0% Net Income, excluding certain discrete items, of $61.3 million, an increase of 60.5% Adjusted EBITDA, excluding Medicare Cap, of $80.6 million, an increase of 20.6% Adjusted EBITDA margin, excluding Medicare Cap, of 18.2%, an increase of 196-basis points Roto-Rooter segment operating results: Revenue of $229.9 million, an increase of 3.3% Net Income, excluding certain discrete items, of $33.8 million, essentially flat Adjusted EBITDA of $48.5 million, essentially flat Adjusted EBITDA margin of 21.1%, a decline of 77-basis points VITAS VITAS net revenue was $443.3 million in the second quarter of 2026, which is an increase of 11.9% when compared to the prior-year period.

CINCINNATI, July 01, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the second quarter ended June 30, 2026, on Tuesday, July 28, 2026, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m.

CHE's VITAS growth and Roto-Rooter improvements support its outlook, but inflation, tariffs and competitive pressures remain key risks.

Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Aveanna Healthcare (AVAH) and Chemed (CHE). But which of these two stocks presents investors with the better value opportunity right now?

CINCINNATI, June 08, 2026 (GLOBE NEWSWIRE) -- Roto-Rooter Services Company, a wholly owned subsidiary of Chemed Corporation ("Chemed") (NYSE: CHE) announced it has acquired a formerly independent Roto-Rooter franchise serving 21 counties in south Texas for approximately $12.0 million. The service area includes the cities of Corpus Christi, McAllen, Laredo and Brownsville, Texas.

Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Aveanna Healthcare (AVAH) or Chemed (CHE). But which of these two stocks is more attractive to value investors?
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CHE and any ticker you trade — then tracks every position and per-strategy win rate.